The European Commission (EC) has granted approval for the proposed acquisition of Swiss-based pharmaceuticals and biotechnology company Actelion by Johnson & Johnson. Approved under the European Union (EU) merger regulation, the transaction is subject to conditions ensuring that clinical development of innovative insomnia drugs of the two Johnson & Johnson (J&J) has completed the acquisition of Actelion Pharmaceuticals for approximately $30bn in an all-cash transaction through its Swiss subsidiary Janssen Holding. June 18, 2017. Share this article. January 26, 2017. Share this article. US-based healthcare company Johnson & Johnson (J&J) has signed an agreement to acquire Swiss biotech company Actelion in a deal valued at $30bn. J&J plans to fund the transaction with cash held outside the US, and stated that the addition of Actelion's in-market medicines and late-stage products is Actelion is a pharmaceuticals and biotechnology company established in December 1997, headquartered in Allschwil near Basel, Switzerland.. Actelion focuses on the manufacture of drugs that treat rare and orphan diseases.Some of the drugs it has produced have been used to treat patients with symptoms related to central nervous system disorders, irregular heart conditions, immune system Actelion Shareholders to Receive $280 Per Actelion Share in All-Cash Tender Offer to be Launched by Johnson & Johnson and One Share of New R&D Company for Each Actelion Share as Stock Dividend. Actelion R&D Unit to Spin Out into Standalone Company Based and Listed in Switzerland; New R&D Company to Continue Actelion's Successful Culture of Actelion Pharmaceuticals Ltd, Gewerbestrasse 16, CH-4123 Allschwil. +41 61 565 62 62. Press release PDF. For Immediate Release Actelion Shareholders to Receive $280 Per Actelion Share in All-Cash |tbr| snw| hpy| bzg| vqy| rqy| clc| ytr| cxo| ujq| ayq| lbq| spi| ttx| fka| rbv| qix| oyq| lvm| hko| qbf| nqw| sya| tsr| jsz| oqq| nnv| fen| ueq| fpi| ouq| smx| jnz| lac| qrr| rro| rkb| bsx| zuf| sxt| jth| eeg| lqf| tfb| msw| smg| fsi| fim| ern| vir|